In a world first, Tryptamine Therapeutics is using intravenously delivered psilocybin in a binge-eating disorder clinical trial.
Good morning! Here’s everything you need to know, and some things you don’t, before the ASX flings open its doors and begins trading today.
As Buffett steps back after a legendary run, does his favourite market gauge suggest the Aussie market might be running a little rich?
A major VC fund is using AI to unearth the next $1bn tech unicorn and says its tool has already identified eight ‘standout portfolio companies’ that will deliver for investors.
Albion Resources zeroes in on ‘walk-up’ drill targets ahead of maiden program to unlock secrets of an underexplored but high potential WA gold field.
